H
Harlan M. Krumholz
Researcher at Yale University
Publications - 1966
Citations - 177853
Harlan M. Krumholz is an academic researcher from Yale University. The author has contributed to research in topics: Myocardial infarction & Population. The author has an hindex of 85, co-authored 1826 publications receiving 159216 citations. Previous affiliations of Harlan M. Krumholz include Veterans Health Administration & Robert Wood Johnson Foundation.
Papers
More filters
Journal ArticleDOI
Polypharmacy and comorbidity in heart failure
TL;DR: Practitioners typically face the challenge of managing not a single condition but multiple conditions requiring multiple medications, as the population ages.
Journal ArticleDOI
Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals.
Nicholas S. Downing,Nilay Shah,Joseph H. Neiman,Jenerius A. Aminawung,Harlan M. Krumholz,Joseph S. Ross +5 more
TL;DR: Although women are equally represented in pivotal trials supporting recent novel therapeutic approvals by the FDA, elderly patients and those from racial and ethnic minorities are underrepresented.
Journal ArticleDOI
Summary of evidence regarding hospital strategies to reduce door-to-balloon times for patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Elizabeth H. Bradley,Brahmajee K. Nallamothu,Jeptha P. Curtis,Tashonna R. Webster,Tashonna R. Webster,David J. Magid,David J. Magid,Christopher B. Granger,Mauro Moscucci,Harlan M. Krumholz +9 more
TL;DR: Although evidence of "what works" is based on observational studies rather than randomized trials, there is evidence on effective interventions to reduce door-to-balloon time.
Journal ArticleDOI
Factors Associated With Racial Differences in Myocardial Infarction Outcomes
TL;DR: Although black patients with myocardial infarction have worse outcomes than white patients, these differences did not persist after adjustment for patient factors and site of care, and strategies that focus on improving baseline cardiac risk and hospital factors may do more than treatment-focused strategies to attenuate racial differences.
Journal ArticleDOI
Clinical utility of transthoracic two-dimensional and Doppler echocardiography☆
TL;DR: The value of contemporary echocardiography for patient diagnosis and management in clinical practice was determined on the basis of both clinical and cost-effectiveness criteria and it was found that the eChocardiogram commonly provided information that was unexpected.